[28B-pm] Structure-activity relationship-4

Mon. Mar 28, 2022 3:42 PM - 4:54 PM [Room B] Conference Room 131+132 (Bldg. 1: 3F)

Chair: Mitsuyasu Kawaguchi

+Add all to schedule

3:42 PM - 3:54 PM

[28B-pm01S] Structure-Activity Relationship Study of 2-Pyrrolone Derivatives, STK160830 as Radioprotector

○Hidetoshi Satoh¹, Shintaro Ochi², Shohei Ujita², Miyu Toyoda², Yuichi Nishiyama², Kasumi Tada², Yosuke Matsushita^2,3, Yuichi Deguchi³, Keiji Suzuki³, Yoshimasa Tanaka³, Hiroshi Ueda³, Toshiya Inaba⁴, Yoshio Hosoi⁵, Akinori Morita², Shin Aoki^1,6 (1. Grad. Sch. Pharm. Sci., Tokyo Univ. of Sci., 2. Grad. Sch. Biomed. Sci., Tokushima Univ., 3. Dept. Pharm. Ther. Innov., Nagaski Univ., 4. Res. Inst. Rad. Biol. Med., Hiroshima Univ., 5. Dept. Rad. Biol., Tohoku Univ., 6. Res. Inst. Sci. Tech., Tokyo Univ. of Sci.)

3:54 PM - 4:06 PM

[28B-pm02] Synthesis and radical scavenging activity of novel tocopherol analogs with nitrogen-containing heterocycles

○Yuta Okayama¹, Masataka Mochizuki¹, Keiko Inami¹ (1. Faculty of Pharmaceutical Sciences, Sanyo-Onoda City University)

4:06 PM - 4:18 PM

[28B-pm03S] Development of novel delta opioid receptor selective agonists with pyrazolomorphinan skeleton

○Saki Ishizaki¹, Shigeto Hirayama¹, Chiharu Iwamatsu¹, Junich Niwa¹, Megan E. Reid², Hideo Nakamura², Hideaki Fujii¹ (1. Grad. Sch. Pharm. Sci., Kitasato Univ., 2. Nippon Chemiphar Co., Ltd.)

4:18 PM - 4:30 PM

[28B-pm04S] Development of liver X receptor (LXR) β-selective ligands based on silicon-containing compounds

○Nao Namba¹, Tomomi Noguchi Yachide², Yuichiro Matsumoto², Yuichi Hashimoto², Hiroyuki Kagechika¹, Shinya Fujii¹ (1. Institute of Biomaterials and Bioengineering, Tokyo Medical and Dental University, 2. Institute for Quantitative Biosciences, The University of Tokyo)

4:30 PM - 4:42 PM

[28B-pm05] The visualization of the fresh state of cyclic peptide drugs in solution utilizing MAXS measurement

○Takashi Matsumoto¹, Takashi Sato¹, Akihito Yamano¹ (1. Rigaku Corporation)

4:42 PM - 4:54 PM

[28B-pm06S] Synthesis of conformationally restricted negamycin derivatives and its readthrough activity

○Noriko Omura¹, Akihiro Taguchi¹, Keisuke Hamada¹, Tomoki Kuwahara², Mizuki Watanabe², Masanori Nakakuki³, Sho Konno¹, Kentaro Takayama¹, Atsuhiko Taniguchi¹, Toshifumi Nomura^4,5, Satoshi Shuto², Yoshio Hayashi¹ (1. Sch. Pharm., Tokyo Univ. of Pharm. and Life Sci., 2. Fac. Pharm. Sci., Hokkaido Univ., 3. Mochida Pharm. Co., Ltd., 4. Hokkaido Univ. Grad. Sch. of Med., 5. Fac. Med., Univ. of Tsukuba)

Session information